(Q36981265)

17 August 2017

1 reference

title

Innovative approaches for the treatment of depression: targeting the HPA axis (English)

1 reference

17 August 2017

Fiona Thomson

1

1 reference

17 August 2017

Mark Craighead

series ordinal

2

1 reference

17 August 2017

publication date

25 October 2007

1 reference

17 August 2017

published in

Neurochemical Research

1 reference

17 August 2017

volume

33

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

691-707

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-007-9518-3

17 August 2017

exact match

0 references

cites work

Vasopressin released within the septal brain area during swim stress modulates the behavioural stress response in rats.

1 reference

12 December 2020

Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain

1 reference

12 December 2020

Changes in Cerebrospinal Fluid Neurochemistry During Treatment of Obsessive-compulsive Disorder With Clomipramine

1 reference

12 December 2020

The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats.

1 reference

12 December 2020

The involvement of the vasopressin system in stress-related disorders

1 reference

12 December 2020

Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.

1 reference

12 December 2020

Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation.

1 reference

12 December 2020

DST studies in psychotic depression: a meta-analysis

1 reference

12 December 2020

Aging and hypothalamic-pituitary-adrenal response to challenge in humans

1 reference

12 December 2020

Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist

1 reference

12 December 2020

Activation of the locus coeruleus noradrenergic system by intracoerulear microinfusion of corticotropin-releasing factor: effects on discharge rate, cortical norepinephrine levels and cortical electroencephalographic activity.

1 reference

12 December 2020

Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model.

1 reference

12 December 2020

Elevated cortisol levels in Cushing's disease are associated with cognitive decrements

1 reference

12 December 2020

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

1 reference

12 December 2020

Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia.

1 reference

12 December 2020

Urinary free cortisol excretion in depression

1 reference

12 December 2020

A single social defeat experience selectively stimulates the release of oxytocin, but not vasopressin, within the septal brain area of male rats

1 reference

12 December 2020

Dissociation between pituitary and adrenal suppression to dexamethasone in depression.

1 reference

12 December 2020

Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects

1 reference

12 December 2020

Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders.

1 reference

12 December 2020

Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications

1 reference

12 December 2020

Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression

1 reference

12 December 2020

Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor

1 reference

12 December 2020

Treatment with the CRH1-receptor-antagonist R121919 improves sleep-EEG in patients with depression

1 reference

12 December 2020

Desmopressin normalizes the blunted adrenocorticotropin response to corticotropin-releasing hormone in melancholic depression: evidence of enhanced vasopressinergic responsivity

1 reference

12 December 2020

Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin

1 reference

12 December 2020

Hippocampal atrophy in recurrent major depression

1 reference

12 December 2020

Diagnosis and definition of treatment-resistant depression

1 reference

12 December 2020

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

1 reference

12 December 2020

Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919).

1 reference

12 December 2020

A corticosteroid/dopamine hypothesis for psychotic depression and related states

1 reference

12 December 2020

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

1 reference

12 December 2020

Adrenal steroid type I and type II receptor binding: estimates of in vivo receptor number, occupancy, and activation with varying level of steroid.

1 reference

12 December 2020

The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions.

1 reference

12 December 2020

Mice with genetically altered glucocorticoid receptor expression show altered sensitivity for stress-induced depressive reactions.

1 reference

12 December 2020

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.

1 reference

12 December 2020

Further neuroendocrine evidence of enhanced vasopressin V3 receptor responses in melancholic depression

1 reference

12 December 2020

Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice

1 reference

12 December 2020

Effects of transgenic overproduction of CRH on anxiety-like behaviour

1 reference

12 December 2020

Psychological stress increases histone H3 phosphorylation in adult dentate gyrus granule neurons: involvement in a glucocorticoid receptor-dependent behavioural response.

1 reference

12 December 2020

Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment

1 reference

12 December 2020

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

1 reference

12 December 2020

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures

1 reference

12 December 2020

4-(2-Chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]5-methyl-N-(2-propynyl)-1, 3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II.

1 reference

12 December 2020

The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.

1 reference

12 December 2020

Treatment with a CRH-1-receptor antagonist (R121919) does not affect weight or plasma leptin concentration in patients with major depression

1 reference

12 December 2020

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

1 reference

12 December 2020

Hippocampal cell proliferation regulation by repeated stress and antidepressants.

1 reference

12 December 2020

Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression

1 reference

12 December 2020

Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder

1 reference

12 December 2020

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

1 reference

12 December 2020

The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum.

1 reference

12 December 2020

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

1 reference

12 December 2020

Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary

1 reference

12 December 2020

The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones

1 reference

12 December 2020

Treatment of major depression with steroid suppressive drugs

1 reference

12 December 2020

Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety.

1 reference

12 December 2020

Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress?

1 reference

12 December 2020

Blunted Corticotropin and Normal Cortisol Response to Human Corticotropin-Releasing Factor in Depression

1 reference

12 December 2020

Vasopressin cells in the medial amygdala of the rat project to the lateral septum and ventral hippocampus

1 reference

12 December 2020

Stress and hippocampal neurogenesis

1 reference

12 December 2020

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease

1 reference

12 December 2020

Cortisol response to vasopressin in depression.

1 reference

12 December 2020

Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites

1 reference

12 December 2020

1 reference

12 December 2020

Dissociated central and peripheral release of vasopressin, but not oxytocin, in response to repeated swim stress: new insights into the secretory capacities of peptidergic neurons

1 reference

12 December 2020

Cerebrospinal fluid vasopressin--changes in depression

1 reference

12 December 2020

Effect of Chronic Administration of Selective Glucocorticoid Receptor Antagonists on the Rat Hypothalamic–Pituitary–Adrenocortical Axis

1 reference

12 December 2020

Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol

1 reference

12 December 2020

Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415.

1 reference

12 December 2020

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

1 reference

12 December 2020

Antidepressants and hypothalamic-pituitary-adrenocortical regulation

1 reference

12 December 2020

A meta-analytic review of the effects of acute cortisol administration on human memory.

1 reference

12 December 2020

Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.

1 reference

12 December 2020

Plasma levels of arginine vasopressin elevated in patients with major depression.

1 reference

12 December 2020

Do antidepressants regulate how cortisol affects the brain?

1 reference

12 December 2020

Let the facts prevail

1 reference

12 December 2020

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

1 reference

12 December 2020

Cortisol secretion in endogenous depression. I. Basal plasma levels.

1 reference

12 December 2020

Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin

1 reference

12 December 2020

Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment

1 reference

12 December 2020

Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?

1 reference

12 December 2020

Transduction of psychosocial stress into the neurobiology of recurrent affective disorder

1 reference

12 December 2020

Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin

1 reference

12 December 2020

[Corticosterone secretion in humans. 3. Secretory rate of corticosterone and cortisol during stimulation of the adrenal cortex with ACTH].

1 reference

12 December 2020

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated.

1 reference

12 December 2020

Vasopressin V1b receptor knockout reduces aggressive behavior in male mice

1 reference

12 December 2020

Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.

1 reference

12 December 2020

Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain

1 reference

12 December 2020

Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications

1 reference

12 December 2020

Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.

1 reference

12 December 2020

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.

1 reference

12 December 2020

The therapeutic potential of CRF1 antagonists for anxiety

1 reference

12 December 2020

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

12 December 2020

Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats.

1 reference

12 December 2020

Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system.

1 reference

12 December 2020

Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls

1 reference

12 December 2020

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

1 reference

12 December 2020

Cerebrospinal fluid vasopressin in neurological and psychiatric disorders

1 reference

12 December 2020

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

1 reference

12 December 2020

Lifelong corticosterone level determines age-related decline in neurogenesis and memory.

1 reference

12 December 2020

The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications

1 reference

12 December 2020

Hyper-reactive hypothalamo-pituitary-adrenocortical axis in rats bred for high anxiety-related behaviour.

1 reference

12 December 2020

Treatment of major depression with metyrapone and hydrocortisone

1 reference

12 December 2020

Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder

1 reference

12 December 2020

Anxious-retarded depression: relation with plasma vasopressin and cortisol

1 reference

12 December 2020

Cortisol secretion in endogenous depression. II. Time-related functions.

1 reference

12 December 2020

Antiglucocorticoid therapies in major depression: a review

1 reference

12 December 2020

Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons

1 reference

12 December 2020

How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions

1 reference

12 December 2020

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.

1 reference

12 December 2020

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

12 December 2020

The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress

1 reference

12 December 2020

The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats

1 reference

12 December 2020

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

1 reference

12 December 2020

Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions*

1 reference

12 December 2020

Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients

1 reference

12 December 2020

The hypothalamic-pituitary-adrenal axis response to stress in mice lacking functional vasopressin V1b receptors

1 reference

12 December 2020

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

1 reference

12 December 2020

HPA axis responses to laboratory psychosocial stress in healthy elderly adults, younger adults, and children: impact of age and gender

1 reference

12 December 2020

Biphasic inhibition of adrenocorticotropin release by corticosterone in cultured anterior pituitary cells.

1 reference

12 December 2020

Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome

1 reference

12 December 2020

Effects of corticosterone treatment and rehabilitation on the hippocampal formation of neonatal and adult rats. An unbiased stereological study.

1 reference

12 December 2020

Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression

1 reference

12 December 2020

Ketoconazole administration in hypercortisolemic depression

1 reference

12 December 2020

Effect of combined treatment with imipramine and metyrapone on the immobility time, the activity of hypothalamo-pituitary-adrenocortical axis and immunological parameters in the forced swimming test in the rat.

1 reference

12 December 2020

Altered serotonergic neurotransmission but normal hypothalamic-pituitary-adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775.

1 reference

12 December 2020

Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review

1 reference

12 December 2020

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial

1 reference

12 December 2020

Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo

1 reference

12 December 2020

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

12 December 2020

Stress and memory: opposing effects of glucocorticoids on memory consolidation and memory retrieval

1 reference

12 December 2020

Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis.

1 reference

12 December 2020

Vasopressin in CSF and plasma in depressed suicide attempters: preliminary results

1 reference

12 December 2020

Steroid 11 beta-hydroxylase deficiency and related disorders

1 reference

12 December 2020

Rapid reversal of psychotic depression using mifepristone

1 reference

12 December 2020

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

12 December 2020

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

1 reference

12 December 2020

Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression

1 reference

12 December 2020

P-Glycoprotein, a gatekeeper in the blood-brain barrier

1 reference

12 December 2020

A pilot study of noradrenergic and HPA axis functioning in PTSD vs. panic disorder

1 reference

12 December 2020

Brain mineralocorticoid receptor function

1 reference

12 December 2020

The vasopressin V1b receptor as a therapeutic target in stress-related disorders

1 reference

12 December 2020

The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action

1 reference

12 December 2020

Social motivation is reduced in vasopressin 1b receptor null mice despite normal performance in an olfactory discrimination task

1 reference

12 December 2020

Central serotonergic responses and behavioural adaptation to repeated immobilisation: the effect of the corticosterone synthesis inhibitor metyrapone

1 reference

12 December 2020

Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states

1 reference

12 December 2020

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)

1 reference

12 December 2020

The behavioural effects of corticotropin-releasing factor-related peptides in rats

1 reference

12 December 2020

Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone

1 reference

12 December 2020

Hypothalamic-pituitary-adrenal axis activity and sleep in posttraumatic stress disorder

1 reference

12 December 2020

Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide

1 reference

12 December 2020

Clinical applications of the dexamethasone suppression test for endogenous depression

1 reference

12 December 2020

Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model.

1 reference

12 December 2020

Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects

1 reference

12 December 2020

Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486)

1 reference

12 December 2020

Corticosteroid receptor function is decreased in depressed patients

1 reference

12 December 2020

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls.

1 reference

12 December 2020

The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy

1 reference

12 December 2020

Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

1 reference

12 December 2020

Psychosocial stress, glucocorticoids, and structural alterations in the tree shrew hippocampus

1 reference

12 December 2020

Vasopressin coexists in half of the corticotropin-releasing factor axons present in the external zone of the median eminence in normal rats

1 reference

12 December 2020

Neuroendocrine responses to inhibitors of steroid biosynthesis in patients with major depression resistant to antidepressant therapy.

1 reference

12 December 2020

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

1 reference

12 December 2020

Cortisol synthesis inhibition: A new treatment strategy for the clinical and endocrine manifestations of depression

1 reference

12 December 2020

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

1 reference

12 December 2020

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

12 December 2020

Dose response of arginine vasopressin to the CCK-B agonist pentagastrin

1 reference

12 December 2020

Attenuated stress-induced catecholamine release in mice lacking the vasopressin V1b receptor

1 reference

12 December 2020

Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression

1 reference

12 December 2020

Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder

1 reference

12 December 2020

Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression

1 reference

12 December 2020

Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.

1 reference

12 December 2020

Regulation of pituitary vasopressin V1b receptor mRNA during stress in the rat.

1 reference

12 December 2020

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

1 reference

12 December 2020

The Longitudinal Course of Psychopathology in Cushing’s Syndrome after Correction of Hypercortisolism

1 reference

12 December 2020

10.1007/S11064-007-9518-3

Identifiers

DOI

1 reference

17 August 2017

1 reference